secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oruka Therapeutics, Inc. (ORKA)
CIK:        0000907654
Form:       8-K
Filed at:   2023-12-05T23:59:59+00:00
Accession:  0000950170-23-068189
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.08, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ARCA biopharma sets Jan 30, 2024 annual meeting, Dec 6 record date, Dec 11 proposal deadline
--------------------------------------------------------------------------------

- Annual meeting scheduled for January 30, 2024; record date for voting is December 6, 2023.
- Shareholder proposals or director nominations must be received by December 11, 2023.
- Proxy materials expected to be available beginning on or about December 19, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/907654/000095017023068189/0000950170-23-068189-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/907654/000095017023068189/abio-20231204.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-068189

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer